These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 4995562)

  • 1. Automated immunoprecipitin technique for analysis of the third component of complement (C'3) in human serum.
    Killingsworth LM; Savory J; Teague PO
    Clin Chem; 1971 May; 17(5):374-7. PubMed ID: 4995562
    [No Abstract]   [Full Text] [Related]  

  • 2. Breakdown products of C 3 in human synovial fluids.
    Zvaifler NJ
    J Clin Invest; 1969 Aug; 48(8):1532-42. PubMed ID: 4183680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3.
    da Silva WD; Eisele JW; Lepow IH
    J Exp Med; 1967 Dec; 126(6):1027-48. PubMed ID: 6069927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia.
    Petz LD; Fink DJ; Letsky EA; Fudenberg HH; Müller-Eberhard J
    J Clin Invest; 1969 Nov; 47(11):2469-84. PubMed ID: 4975569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Identification of the C'3 component of human complement by electrophoresis on polyacrylamide gel].
    Lamy J; Vargues R; Weill J
    C R Seances Soc Biol Fil; 1967; 161(10):2021-5. PubMed ID: 4175793
    [No Abstract]   [Full Text] [Related]  

  • 6. [Diagnostic value of the determination of C'3 (beta 1 C-beta 1 A) in immunological reactions].
    Barboni F; Poggi EA
    Boll Soc Ital Biol Sper; 1969 Aug; 45(16):1070-3. PubMed ID: 4986926
    [No Abstract]   [Full Text] [Related]  

  • 7. Inherited deficiency of the third component of human complement (C'3).
    Alper CA; Propp RP; Klemperer MR; Rosen FS
    J Clin Invest; 1969 Mar; 48(3):553-7. PubMed ID: 5773091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic polymorphism of the third component of human complement (C'3).
    Alper CA; Propp RP
    J Clin Invest; 1968 Sep; 47(9):2181-91. PubMed ID: 5675433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum C'3 lytic system in patients with glomerulonephritis.
    Spitzer RE; Vallota EH; Forristal J; Sudora E; Stitzel A; Davis NC; West CD
    Science; 1969 Apr; 164(3878):436-7. PubMed ID: 4180576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the third component (C'3) of guinea pig complement. I. Purification and characterization.
    Yonematsu K; Inoue K
    Biken J; 1968 Sep; 11(3):169-80. PubMed ID: 4976235
    [No Abstract]   [Full Text] [Related]  

  • 11. [Determination of total complementary activity and of its 4 fractions: C'1, C'2, C'3 and C'4 in the serum and urine].
    Hartmann L; Brécy H
    Ann Biol Clin (Paris); 1969; 27(7):559-70. PubMed ID: 5354248
    [No Abstract]   [Full Text] [Related]  

  • 12. Automated immunochemical procedures for measurement of immunoglobulins IgG, IgA, and IgM in human serum.
    Killingsworth LM; Savory J
    Clin Chem; 1971 Sep; 17(9):936-40. PubMed ID: 4999030
    [No Abstract]   [Full Text] [Related]  

  • 13. A plasmin-split fragment of C'3 as a new chemotactic factor.
    Ward PA
    J Exp Med; 1967 Aug; 126(2):189-206. PubMed ID: 4226271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.
    Alper CA; Rosen FS
    J Clin Invest; 1967 Dec; 46(12):2021-34. PubMed ID: 6074005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.
    Cochrane CG; Müller-Eberhard HJ
    J Exp Med; 1968 Feb; 127(2):371-86. PubMed ID: 4383923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manual and automated determination of immunoglobulins in unconcentrated cerebrospinal fluid.
    Savory J; Heintges MG; Killingsworth LM; Potter JM
    Clin Chem; 1972 Jan; 18(1):37-42. PubMed ID: 4621409
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum complement (C'3) levels in patients with autoimmune bullous skin diseases.
    Katz SI; Inderbitzin TM; Halprin KM
    Arch Dermatol; 1970 Oct; 102(4):368-70. PubMed ID: 4990488
    [No Abstract]   [Full Text] [Related]  

  • 18. Serum complement component C'3 values in patients with various diseases at a military hospital.
    Stroud MB
    Mil Med; 1970 Dec; 135(12):1105-26. PubMed ID: 5005797
    [No Abstract]   [Full Text] [Related]  

  • 19. Differentiation of human IgM subclasses by the ability to interact with a factor resembling the first component of complement.
    Mackenzie MR; Warner NL; Linscott WD; Fudenberg HH
    J Immunol; 1969 Sep; 103(3):607-12. PubMed ID: 4979781
    [No Abstract]   [Full Text] [Related]  

  • 20. Levels of C'3 in the serum of patients with pemphigus.
    Ablin RJ
    J Invest Dermatol; 1971 Jun; 56(6):450-3. PubMed ID: 4103072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.